JBIO

Jade Biosciences Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth 8/10
  • Momentum 7/10
Jade Biosciences sales and earnings growth
JBIO Growth
Good
  • Revenue Y/Y 0.00%
  • EPS Y/Y 88.29%
  • FCF Y/Y -9.89%
Jade Biosciences gross and profit margin trends
JBIO Profitability
Low
  • Gross margin 0.00%
  • EPS margin 0.00%
  • ROIC -107.30%
Jade Biosciences recent dividend growth
JBIO Dividends
  • Dividend yield 17.09%
  • Growth 3Y 0.00%
  • Payout ratio -23%
Jade Biosciences net debt vs free cash flow
JBIO Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage NA

Jade Biosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗